Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis, Biological Activity, and Molecular Dynamics Study of Novel Series of a Trimethoprim Analogs as Multi-Targeted Compounds: Dihydrofolate Reductase (DHFR) Inhibitors and DNA-Binding Agents
Agnieszka Wróbel, Maciej Baradyn, Artur Ratkiewicz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3685-3685
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

The interaction mechanism of candidone with calf thymus DNA: A multi-spectroscopic and MD simulation study
Mahvash Farajzadeh Dehkordi, Sadegh Farhadian, Fatemeh Hashemi-Shahraki, et al.
International Journal of Biological Macromolecules (2023) Vol. 235, pp. 123713-123713
Closed Access | Times Cited: 17
Coupling micro-electric field into aerobic granular sludge system for sulfadiazine abatement: Performance, mechanism, toxicity, and microbial characteristics
Yabin Li, Menghan Guo, Xiuqin Kong, et al.
Chemical Engineering Journal (2024) Vol. 483, pp. 149258-149258
Closed Access | Times Cited: 6
A Novel Method of Magnetic Nanoparticles Functionalized with Anti-Folate Receptor Antibody and Methotrexate for Antibody Mediated Targeted Drug Delivery
Madeeha Shahzad Lodhi, Fatimah Khalid, Muhammad Tahir Khan, et al.
Molecules (2022) Vol. 27, Iss. 1, pp. 261-261
Open Access | Times Cited: 23
Exploring the interactions of rapamycin with target receptors in A549 cancer cells: insights from molecular docking analysis
Sanjeev K. Ganesh, C. Subathra Devi
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 1
Open Access
Design, synthesis, antimalarial activity, and in-silico studies of new benzimidazole/pyridine hybrids as dihydrofolate reductase inhibitors
Martha M. Morcoss, Jakline Nelson Saddik, Mariam E. Amin, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108171-108171
Closed Access
Rational design, synthesis, and molecular modelling insights of dual DNA binders/DHFR inhibitors bearing arylidene-hydrazinyl-1,3-thiazole scaffold with apoptotic and anti-migratory potential in breast MCF-7 cancer cells
Marwa H. El‐Wakil, Rasha Abdelmawla Ghazala, Hadeel A. El-Dershaby, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2025) Vol. 40, Iss. 1
Open Access
Biological Activity of Newly Synthesized Benzimidazole and Benzothizole 2,5-Disubstituted Furane Derivatives
Livio Racané, Ivo Zlatar, Nataša Perin, et al.
Molecules (2021) Vol. 26, Iss. 16, pp. 4935-4935
Open Access | Times Cited: 21
Aegle marvels (L.) Correa Leaf Essential Oil and Its Phytoconstituents as an Anticancer and Anti-Streptococcus mutans Agent
Alhussain Aodah, Mohamed Balaha, Talha Jawaid, et al.
Antibiotics (2023) Vol. 12, Iss. 5, pp. 835-835
Open Access | Times Cited: 7
Targeting decaprenylphosphoryl-β-D-ribose 2′-epimerase for Innovative Drug Development Against Mycobacterium Tuberculosis Drug-Resistant Strains
Ghyzlane EL Haddoumi, Mariam Mansouri, Jouhaina Kourou, et al.
Bioinformatics and Biology Insights (2024) Vol. 18
Open Access | Times Cited: 2
Evaluation of a Conformationally Constrained Indole Carboxamide as a Potential Efflux Pump Inhibitor in Pseudomonas aeruginosa
Yongzheng Zhang, Jesús D. Rosado-Lugo, Pratik Datta, et al.
Antibiotics (2022) Vol. 11, Iss. 6, pp. 716-716
Open Access | Times Cited: 12
Targeting cellular metabolism in head and neck cancer precision medicine era: A promising strategy to overcome therapy resistance
Lin Xiaohu, Wenkai Zhou, Zheqi Liu, et al.
Oral Diseases (2022) Vol. 29, Iss. 8, pp. 3101-3120
Closed Access | Times Cited: 9
Enhancing the dissolution and bacteriostatic activity of trimethoprim through salt formation
Xingchen Hu, Yuntian Xiao, Luguang Qi, et al.
CrystEngComm (2023) Vol. 25, Iss. 23, pp. 3445-3459
Closed Access | Times Cited: 5
Selective Non-toxics Inhibitors Targeting DHFR for Tuberculosis and Cancer Therapy: Pharmacophore Generation and Molecular Dynamics Simulation
Ghyzlane EL Haddoumi, Mariam Mansouri, Houda Bendani, et al.
Bioinformatics and Biology Insights (2023) Vol. 17
Open Access | Times Cited: 4
Benzamide Trimethoprim Derivatives as Human Dihydrofolate Reductase Inhibitors—Molecular Modeling and In Vitro Activity Study
Danuta Drozdowska, Agnieszka Wróbel, Cezary Parzych, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1079-1079
Open Access | Times Cited: 1
Theoretical and experimental study of pharmaceutical salts: A case of Trimethoprim
Liang Zhang, Di Wu, Menglong Zhang, et al.
CrystEngComm (2024) Vol. 26, Iss. 28, pp. 3808-3822
Closed Access | Times Cited: 1
Betalains from Opuntia stricta peels: UPLC-MS/MS metabolites profiling, computational investigation, and potential applicability as a raw meat colorant
Moufida Chaari, Sarra Akermi, Khaoula Elhadef, et al.
Heliyon (2024) Vol. 10, Iss. 21, pp. e39784-e39784
Open Access | Times Cited: 1
Synthesis of Novel Derivatives of 5,6,7,8-Tetrahydroquinazolines Using α-Aminoamidines and In Silico Screening of Their Biological Activity
Arsenii D. Snizhko, Alexander Kyrychenko, Eugene S. Gladkov
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3781-3781
Open Access | Times Cited: 3
Identification of Active Compounds against Melanoma Growth by Virtual Screening for Non-Classical Human DHFR Inhibitors
Andrés Felipe Vásquez, Luis Alberto Gómez, Andrés Fernando González Barrios, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13946-13946
Open Access | Times Cited: 3
Computational investigations into structure and function impact of novel mutations identified in targeted exons from ovarian cancer cell lines
Rucha M. Wadapurkar, Aruna Sivaram, Renu Vyas
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-15
Closed Access
Synthesis and Characterization of Naproxen-Salicylate Derivatives as Potential Dual-Targeted Inhibitors of Dihydrofolate Reductase
Syon Schlecht, Emily Gunderson, Ruthie Fowler, et al.
Advances in Biological Chemistry (2024) Vol. 14, Iss. 04, pp. 87-102
Open Access
New 6-nitro-4-substituted quinazoline derivatives targeting epidermal growth factor receptor: design, synthesis and in vitro anticancer studies
Ayman Farag, Aya H Othman, Mohamed K. El‐Ashrey, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 19, pp. 2025-2041
Closed Access
Synthesis, in vitro biological evaluation and in silico studies of novel pyrrolidine derived thiosemicarbazones as dihydrofolate reductase inhibitors
Hina Aftab, Naeem Ullah, Ajmal Khan, et al.
RSC Advances (2024) Vol. 14, Iss. 43, pp. 31409-31421
Open Access
Synthesis and characterization of 2-(3,4-dihydroxyphenyl)-4-((4-hydroxyphenyl)imino)-4h-chromene-3,5,7-triol: In vitro biological evaluation and computational analysis
Udaya Rajesh R, D. Sangeetha
Journal of Molecular Structure (2024) Vol. 1322, pp. 140562-140562
Closed Access
Biological Evaluation of 2-(3,4-dihydroxyphenyl)-4-((4-methoxyphenyl)imino)-4H-chromene-3,5,7-triol: Design, Synthesis, and Molecular Docking Studies
Udaya Rajesh R, D. Sangeetha
Biocatalysis and Agricultural Biotechnology (2024), pp. 103471-103471
Closed Access
In vitro and in silico anti-malarial activity and cytotoxicity of n-hexyl 1-O-rutinoside (a glycoside) isolated from Annickia polycarpa (DC.) Setten and Maas ex I.M. Turner (Annonaceae)
Emmanuel Kofi Kumatia, Felix Kwame Zoiku, Alex Asase, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117287-117287
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top